ASSET PURCHASE AGREEMENT BY AND BETWEEN JANSSEN BIOTECH, INC. AND MIRUM PHARMACEUTICALS, INC. November 16, 2021Asset Purchase Agreement • November 19th, 2021 • Mirum Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 19th, 2021 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 16, 2021 (the “Effective Date”), by and between JANSSEN BIOTECH, INC., a corporation organized under the laws of Pennsylvania (“Buyer”), and MIRUM PHARMACEUTICALS, INC., a corporation organized under the laws of Delaware (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties.”